Location: Home
  • search
  • go
  • Relate News
  • 3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
  • 3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
  • 3/2/2026NMPA Approves Rovalicitinib for First-Line Myelofibrosis
  • 2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
  • 2/26/2026Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/24/2026Pfizer Acquires China Rights to Sciwind's Approved GLP-1 Therapy
  • 2/24/2026GenSci Advances PD-1 Agonist Into Phase 2b for Rheumatoid Arthritis
  • 2/11/2026GSK's RSV Vaccine Arexvy Moves Forward in China
  • 2/11/2026China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
  • 2/9/2026GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
  • 2/9/2026BioKangtai Cancels Planned Vaccine Joint Venture With AstraZeneca in C...
  • 2/7/2026Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...
  • 2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
  • 2/4/2026China's Health Insurance Market Poised for $596B Surge by 2033
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • 2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...
  • 1/31/2026China's Vaccine Exports Jump More Than 50% in 2025 as Overseas Shipmen...
  • 1/30/2026SciBrunch Raises Over $35M in Oversubscribed Pre-A Round
  • 1/30/2026Sciwind Receives China Approval for Ecnoglutide Injection in Type 2 Di...
  • 1/29/2026Sciwind Reports Positive Phase III Results for Ecnoglutide in T2DM
  • 1/28/2026China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
  • 1/27/2026China's Vaccine Market Set for Slow but Steady Growth Through 2035
  • 1/26/2026CDE Issues Technical Guidance on NMR Studies for Glycoconjugate Vaccin...
  • 1/23/2026Fosun Pharma Moves to Spin Off Vaccine Unit for Hong Kong IPO
  • 1/23/2026China's Commercial Health Insurance Payouts for Innovative Drugs and D...
  • 1/22/2026NMPA Issues New Guidance to Standardize Vaccine Adjuvant Research, Boo...
  • 1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy
  • 1/21/2026Telix Advances China Strategy as Prostate Cancer Imaging Filing Clears...
  • 1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...
  • Page:1/77 Total number of articles:2283: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group